drugset / Trial / NCT00878995
Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma
Phase 1
Completed
28 enrolled
The University of Texas Medical Branch, Galveston
National Cancer Institute (NCI) · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
RATIONALE: Testosterone may lessen weight loss and improve muscle size and strength in patients with cachexia caused by cancer. PURPOSE: This randomized phase I trial is studying whether testosterone administered during standard of care chemotherapy and/or radiation works by helping patients with squamous cell carcinoma to maintain their body weight and muscle size and strength during treatment.
Timeline
- Start
- 2009-06-03
- Primary completion
- 2014-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Testosterone Enanthate | Small molecule | 100 mg | Intramuscular |